Navigation Links
Mylan Launches Generic Version of Zyprexa® Tablets
Date:4/24/2012

PITTSBURGH, April 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg. This product is the generic version of Eli Lilly and Company's Zyprexa®, which is indicated for the treatment of schizophrenia and the acute treatment of manic or mixed episodes associated with bipolar 1 disorder and maintenance treatment of bipolar 1 disorder. [1]

Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg, had U.S. sales of approximately $3.3 billion for the 12 months ending Dec. 31, 2011, according to IMS Health. Mylan is shipping this product immediately.

Currently, Mylan has 171 ANDAs pending FDA approval representing $97.2 billion in annual sales, according to IMS Health. Forty of these pending ANDAs are potential first-to-file opportunities, representing $25.7 billion in annual brand sales, for the 12 months ending Dec. 31, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.

[1] There is an increased
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... EHE International, the recognized leader in preventive medicine and annual ... David Abrams M.D . in Tarzana, CA ... Through David Abrams M.D ., EHE members in the ... to EHE,s preventive care programs to help proactively maintain their ... Abrams M.D. to its growing private provider network. With Dr. ...
(Date:9/16/2014)... 16, 2014  Decision Resources Group finds that the rheumatoid arthritis ... 2013 to over $18.2 billion in 2023 in the ... Germany , Italy , Spain ... Japan . TNF-alpha inhibitors will remain the leading drug ... but growth will be constrained and patient shares will decline due ...
(Date:9/16/2014)... DUBLIN , Sept. 16, 2014 ... addition of the "Global Laparoscopy Devices Industry ... The Global Laparoscopy Devices Industry Report ... the current state of the global laparoscopic devices. ... of the industry including definitions, classifications, applications and ...
Breaking Medicine Technology:EHE International Certifies David Abrams M.D. as Its Newest Partner 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 3Global Laparoscopy Devices Industry Report 2014 2
(Date:9/16/2014)... the University of California, San Diego School of Medicine ... assess the safety and efficacy of a new monoclonal ... most common form of blood cancer in adults. ... used by embryonic cells during early development and exploited ... the latter responsible for 90 percent of all cancer-related ...
(Date:9/16/2014)... LINCOLN, R.I. (PRWEB) September 16, 2014 ... from Sunday, Sept. 14, through Saturday, Sept. 20, ... make sure children are safe and secure while in ... from the National Traffic Highway Safety Administration (NHTSA), ... did not read the instruction manual when installing child ...
(Date:9/16/2014)... 16, 2014 CarePoint Health is ... Leigh Montes, MD, has joined our expanded Bariatric ... Hospital. Our system welcomes Dr. Montes to the ... surgical weight loss center, helps patients achieve long-term ... surgery procedures, including Gastric Sleeve, Gastric Bypass, LAP-BAND ...
(Date:9/16/2014)... Pittsburgh, PA (PRWEB) September 16, 2014 ... recovering well today after undergoing successful heart transplantation surgery ... , Mr. Tekulve, who spent most of his 16-year ... the team as a commentator for Root Sports Pittsburgh, ... his transplant surgeon, Stephen Bailey, MD, surgical director of ...
(Date:9/16/2014)... (HealthDay News) -- Illegal drug use among teens in the ... federal report. Encouragingly, the new study also found ... products among young people between the ages of 12 and ... survey of 70,000 people aged 12 and older across the ... or abuse problems among this age group also dropped from ...
Breaking Medicine News(10 mins):Health News:Novel drug targeting leukemia cells enters clinical trial 2Health News:Amica Offers Tips During Child Passenger Safety Week 2Health News:Top Bariatric Surgeon Joins CarePoint Health 2Health News:Top Bariatric Surgeon Joins CarePoint Health 3Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 3Health News:Fewer U.S. Teens Using Illegal Drugs and Alcohol, Report Finds 2
... Chemo-radiation therapy looks to kill cells on organ,s surface, ... (HealthDay News) -- Patients are being recruited for a ... protocol for pleural mesothelioma, a cancer of the lung,s ... , Currently, the standard treatment is to remove the ...
... how the nervous system and the immune system interact, scientists at The ... which the brain and the spleen communicate. , ... Manhasset, NY (PRWEB) ... nervous system and the immune system interact, scientists at The Feinstein ...
... T. Kennedy DSc, Dean of Tufts University,s Gerald J. ... Policy announced the 3rd Annual Friedman School Symposium, a ... facing industry, policy-makers, academics and thought leaders in the ... September 24th to 26th, 2008. , Fifteen experts will ...
... for Advanced Medical,Education (IAME) announces the release of ... program. Produced in response to a,strong demand by ... 3 CME,credits required for Mammography Center accreditation., ... course,available online at the CME Center of IAME,s ...
... 15 Percent Increase in Prescription Drug,Costs in ... HealthLeaders-InterStudy, NASHVILLE, Tenn., July 21 ... intelligence, reports that Excellus,BlueCross BlueShield will continue ... and public education efforts. According to the,new ...
... (SPI) has,received an R&D contract award from the ... drug candidate for hearing regeneration. SPI has,developed a ... inner ear of mammals involving p27Kip1, a cyclin ... division or proliferation in,many developing cells and tissues ...
Cached Medicine News:Health News:Lung Cancer Trial Targets Asbestos-Related Disease 2Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 2Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 3Health News:'Nutrition Agenda 2008' is focus of Tufts Friedman School Symposium 2Health News:'Nutrition Agenda 2008' is focus of Tufts Friedman School Symposium 3Health News:New York's Excellus BlueCross BlueShield to Continue Generic Medication Promotion to Help Control Costs 2Health News:Sound Pharmaceuticals Receives Additional DoD Funding for Its Hearing Regeneration Product 2
the LabOne Healthcare Group markets laboratory testing to physicians, patients, managed care companies, self-insured employers, wellness companies and hospitals....
... ideal hemostatic gauze for a variety of inpatient ... iX is easy to handle and can be ... sites that are often a challenge faced by ... used to control bleeding in outpatient procedures such ...
Sharp tipped straight scissors. For cutting in the iris plane or cutting peripheral membranes. May also be useful in ROP cases....
Microscissors : Horizontal Scissors...
Medicine Products: